Optimum Methotrexate Exposure in Patients With Suspected or Confirmed CNS Invasive Hematological Malignancies: A Systematic Critical Review Faria, Monteiro Joaquim; Rita, Damas; Rui, Bergantim; More Faria, Monteiro Joaquim; Rita, Damas; Rui, Bergantim; Fernanda, Trigo Less Therapeutic Drug Monitoring. 45(3):287-292, June 2023. Abstract Abstract Favorite PDF Permissions Buy
Dried Blood Spot Sampling in the Monitoring of Anticancer Therapy for Solid Tumors: A Systematic Review Shafiei, Mohsen; Mahmood, Alina; Beale, Philip; More Shafiei, Mohsen; Mahmood, Alina; Beale, Philip; Galettis, Peter; Martin, Jennifer; McLachlan, Andrew J.; Blinman, Prunella Less Therapeutic Drug Monitoring. 45(3):293-305, June 2023. Abstract Abstract Favorite PDF Permissions Buy
Role of Cisplatin Dose Intensity and TPMT Variation in the Development of Hearing Loss in Children Siemens, Angela; Brooks, Beth; Rassekh, S. Rod; More Siemens, Angela; Brooks, Beth; Rassekh, S. Rod; Meijer, Annelot J.M.; van den Heuvel-Eibrink, Mary M.; Xu, Wei; Loucks, Catrina M.; Ross, Colin J.D.; Carleton, Bruce C.; on behalf of the Canadian Pharmacogenomics Network for Drug Safety Consortium Less Therapeutic Drug Monitoring. 45(3):345-353, June 2023. Abstract Abstract Favorite PDF Permissions Buy
Application of User-Centered Codesign Principles to Address Barriers in Therapeutic Drug Monitoring Wong, Sherilyn; Davis, Aaron; Selby, Philip R.; More Wong, Sherilyn; Davis, Aaron; Selby, Philip R.; Khoo, Richie; Gwilt, Ian; Stocker, Sophie L.; Ward, Michael B.; Reuter, Stephanie E. Less Therapeutic Drug Monitoring. 45(3):368-375, June 2023. Abstract Abstract Favorite PDF Permissions Buy SDC
